Portfolio of Gene Editing (CRISPR) Stocks
Here are 4 gene editing stocks that use CRISPR technology.
| 4 Portfolio of Gene Editing (CRISPR) Stocks | ||
|---|---|---|
Name | Symbol | Recent Prices |
| Crispr Therapeutics | CRSP | |
| Editas Medicine | EDIT | |
| Intellia Therapeutics | NTLA | |
| Vertex Pharmaceuticals | VRTX | |
| Sparkline weekly price charts based on Alpha Vantage data. | ||
| 4 Portfolio of Gene Editing (CRISPR) Stocks | ||
|---|---|---|
Name | Symbol | Last Close |
| Crispr Therapeutics | CRSP | $65.35 |
| Editas Medicine | EDIT | $12.24 |
| Intellia Therapeutics | NTLA | $55.96 |
| Vertex Pharmaceuticals | VRTX | $289.54 |
Portfolio Values
To inspect the performance of the Portfolio of Gene Editing (CRISPR) Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Alpha Vantage.All 4 stocks are included in the portfolio computations. The current value of the portfolio assumes that $2,500.00 was invested in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends.The current value of the $10,000 investment is $20,808. The percent return is 108.08%. The annualized return is 15.78%.
| 4 Portfolio of Gene Editing (CRISPR) Stocks Returns | ||
|---|---|---|
Name | Symbol | Monthly Returns & Details |
| Crispr Therapeutics | CRSP | 265.70% |
| Editas Medicine | EDIT | -49.02% |
| Intellia Therapeutics | NTLA | 125.19% |
| Vertex Pharmaceuticals | VRTX | 90.44% |
Portfolio Value Chart for Last 100 Daily Closes